A Day Up For IsoRay, Inc.
Wed, Jan 06, 2021 at 05:30 PM
IsoRay, Inc. (ISR:NYSEMKT) rocketted at $1.42, representing a gain of 167.7%. The stock appeared on our News Catalysts scanner on Tue 05 Jan 21 at 07:22 PM in the 'BIOTECH' category. From Tue 22 Dec 20, the stock recorded 25.00% Up Days and 33.33% Green Days
The stock spiked on Thu 17 Sep 20 at $0.79 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About IsoRay, Inc. (ISR:NYSEMKT)
IsoRay Inc designs and develops personalized brachytherapy products. The company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.
Top 10 Gainers:
- IsoRay, Inc. (ISR:NYSEMKT), 167.67%
- Urban One, Inc. (UONE:NASDAQ), 102.05%
- The9 Limited (NCTY:NASDAQ), 73.95%
- 500.com Limited (WBAI:NYSE), 38.53%
- Vislink Technologies, Inc. (VISL:NASDAQ), 35.62%
- Orchard Therapeutics plc (ORTX:NASDAQ), 33.47%
- Digital Ally, Inc. (DGLY:NASDAQ), 32.48%
- Change Healthcare Inc. (CHNG:NASDAQ), 30.04%
- TAT Technologies Ltd. (TATT:NASDAQ), 29.22%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 28.25%